2012

,

Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of atomoxetine and its metabolites

2012

,

Effects of OCT2 602C>T genetic variant on the pharmacokinetics of lamivudine in Koreans

2012

,

Effects of MRP2 C-24T genetic variant on the pharmacokinetics of valsartan

2012

,

Effects of CYP2C9*3 and *13 Alleles on the pharmacokinetics of candesartan and its metabolite

2011

,

CYP2C9*13 allele has an impact on the pharmacokinetics of irbesartan